MREO Mereo BioPharma Group plc ADRs

Mereo is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:MPH.

$0.79  +0.00 (0.17%)
As of 03/27/2023 13:43:41 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  
IPO date:  04/24/2019
Outstanding shares:  67,742,792
Average volume:  542,372
Market cap:   $56,185,872
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BFX1VB2

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%